Amendment No. 2 Assignment and License AgreementAssignment and License Agreement • September 3rd, 2020 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Massachusetts
This Amendment No. 2 (this “Amendment”) is dated September 2, 2020 (the “Amendment Effective Date”), and is between Vertex Pharmaceuticals Incorporated (“Vertex”) and ViralClear Pharmaceuticals, Inc. (successor-in-interest to Trek Therapeutics, PBC (“Trek”)) and formerly known as NeuroClear Technologies, Inc. (“ViralClear”). Vertex and ViralClear may each be referred to herein individually as a “Party” or collectively as the “Parties.”
